Sector
PharmaceuticalsOpen
₹1.97Prev. Close
₹2.07Turnover(Lac.)
₹2.03Day's High
₹2.07Day's Low
₹1.9752 Week's High
₹052 Week's Low
₹0Book Value
₹-5.39Face Value
₹10Mkt Cap (₹ Cr.)
5.15P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
|---|---|---|---|---|
Equity Capital | 24.88 | 24.88 | 24.88 | 29.26 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.37 | 3.81 | 4.49 | 4.4 |
Net Worth | 28.25 | 28.69 | 29.37 | 33.66 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
|---|---|---|---|---|
Revenue | 14.4 | 28.76 | 13.36 | 2.98 |
yoy growth (%) | -49.93 | 115.31 | 347.99 | -87.06 |
Raw materials | -14.36 | -28.38 | -12.72 | -2.8 |
As % of sales | 99.75 | 98.65 | 95.23 | 94.04 |
Employee costs | -0.09 | -0.09 | -0.08 | -0.11 |
| Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
|---|---|---|---|---|
Profit before tax | -0.93 | -0.73 | 0.15 | -0.4 |
Depreciation | -0.91 | -0.99 | -0.11 | -0.07 |
Tax paid | 0.49 | 0.05 | -0.05 | 0 |
Working capital | -0.21 | -0.38 | 0.54 | -0.12 |
Other operating items |
| Y/e 31 Mar | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -49.93 | 115.31 | 347.99 | -87.06 |
Op profit growth | -154.58 | -16.37 | -189.58 | 46.14 |
EBIT growth | 27.78 | -531.52 | -143.71 | -203.62 |
Net profit growth | -35 | -812.06 | -123.83 | -243.51 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672.5 | 93.86 | 4,01,288.77 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,833.1 | 82.12 | 1,81,397.34 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,485.05 | 24.92 | 1,19,948.65 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,313.15 | 59.26 | 1,12,127.01 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,578 | 56.47 | 1,06,401.47 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
Y Manivardhan Reddy
Whole Time Director & CFO
Y Sonia Reddy
Director
P Naveen Chander Reddy
Director
P Suresh Reddy
Additional Director
Santosh Jagannath Sawant
Flat No 104-106 Lumbini Enclav,
Panjagutta,
Telangana - 500082
Tel: 91-40-23392099/3099
Website: http://www.saamyabiotech.com
Email: info@saamyabiotech.com
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Saamya Bio-tech (India) Ltd was incorporated as a Public Limited Company on August 13, 2002. With the primary objective to carry on the business of manufacture, buy, import, export and generally deal ...
Read More
Reports by Saamya Biotech India Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.